Research map: Synthesis and Biological Activity of Novel Aromatic Aminopropyl Lactams in Two Cancer Cell Models

Back to the article

Papers in this map

  1. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading · Oleg Trott · 2009 · 38809 citations · Cited by this paper
  2. Fragmentation of Vancoresmycin Reveals a Strong Dependence on Global Molecular Architecture for Antibacterial Activity · 2026 · Related
  3. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility · Garrett M. Morris · 2009 · 25921 citations · Cited by this paper
  4. A Priori Design, Combinatorial Synthesis, and Assessment of an Antipackaging Peptide Against Human Immunodeficiency Virus 1: Functional Role of Unnatural Trp Mimetics and Serendipitous Discovery of a Protease Inhibitor · 2026 · Related
  5. AutoDock Vina 1.2.0: New Docking Methods, Expanded Force Field, and Python Bindings · Jérôme Eberhardt · 2021 · 7483 citations · Cited by this paper
  6. Novel Inhibitors of Carbonic Anhydrase I and II Identified by High Throughput Virtual Screening and Validated by X‐Ray Crystallography · 2026 · Related
  7. Highly potent and selective ligands for histamine H3-receptors · J.M. Arrang · 1987 · 907 citations · Cited by this paper
  8. Molecular Hybridization of Clinically Relevant P2X7 Antagonists · 2026 · Related
  9. Drying of Organic Solvents: Quantitative Evaluation of the Efficiency of Several Desiccants · D. Bradley G. Williams · 2010 · 853 citations · Cited by this paper
  10. Identification of a Class of Novel, Selective, Structurally Distinct GluN2A Negative Allosteric Modulators Through Virtual Screening · 2026 · Related
  11. Shaping Polarization Of Tumor-Associated Macrophages In Cancer Immunotherapy · Jing Gao · 2022 · 563 citations · Cited by this paper
  12. Furagin Derivatives—Nitrofuran‐Based Hydrazones as Potential Dual Inhibitors of Thioredoxin Reductase and Carbonic Anhydrases · 2026 · Related
  13. The histamine H3 receptor: from gene cloning to H3 receptor drugs · Rob Leurs · 2005 · 487 citations · Cited by this paper
  14. Medicinal Chemistry of Agents for Cancer Therapy and Diagnosis From Uruguay · 2026 · Related
  15. Three-Dimensional Spheroids as In Vitro Preclinical Models for Cancer Research · Bárbara Fernandes Pinto · 2020 · 449 citations · Cited by this paper
  16. Design and Synthesis of Novel Isoflavene TANK‐Binding Kinase 1 Inhibitors With Anti‐Inflammatory Activity · 2026 · Related
  17. Neurochemical and Behavioral Effects of Ciproxifan, A Potent Histamine H3-Receptor Antagonist · Xavier Ligneau · 1998 · 243 citations · Cited by this paper
  18. Design and Synthesis of Novel Imidazo[4,5‐ c ]pyridine Derivatives, Evaluation of Their Activity Against Hepatitis C Virus and In Silico Prediction of Their Binding Mode to NS4B Protein · 2026 · Related
  19. The histamine H3 receptor as a therapeutic drug target for CNS disorders · Mark J. Gemkow · 2009 · 182 citations · Cited by this paper
  20. Piperazine Derivatives Carrying an Imidazole Ring as Selective Modulators of Human Carbonic Anhydrase Isozymes · 2026 · Related
  21. ISG15 Is a Critical Microenvironmental Factor for Pancreatic Cancer Stem Cells · Bruno Sáinz · 2014 · 177 citations · Cited by this paper
  22. Macrophage polarization in the tumor microenvironment: Emerging roles and therapeutic potentials · Wenru Zhang · 2024 · 173 citations · Cited by this paper
  23. Histamine H3Receptor as a Drug Discovery Target · Michael Y. Berlin · 2010 · 141 citations · Cited by this paper
  24. Histamine receptors and cancer pharmacology: an update · Noelia A Massari · 2018 · 136 citations · Cited by this paper
  25. Molecular Regulation of Histamine Synthesis · Hua Huang · 2018 · 119 citations · Cited by this paper
  26. Influence of imidazole replacement in different structural classes of histamine H3-receptor antagonists · Galina Meier · 2001 · 111 citations · Cited by this paper
  27. Investigating the Underappreciated Hydrolytic Instability of 1,8-Diazabicyclo[5.4.0]undec-7-ene and Related Unsaturated Nitrogenous Bases · Alan M. Hyde · 2019 · 104 citations · Cited by this paper
  28. Pitolisant: First Global Approval · Yahiya Y. Syed · 2016 · 100 citations · Cited by this paper
  29. Randomized Clinical Study of a Histamine H3 Receptor Antagonist for the Treatment of Adults with Attention-Deficit Hyperactivity Disorder · Richard H. Weisler · 2012 · 96 citations · Cited by this paper
  30. A remarkable solvent effect on reductive amination of ketones · Song Song · 2018 · 91 citations · Cited by this paper
  31. A structural chemogenomics analysis of aminergic GPCRs : lessons for histamine receptor ligand design · Albert J. Kooistra · 2013 · 86 citations · Cited by this paper
  32. Allosteric Modulation of GPCRs of Class A by Cholesterol · Ján Jakubík · 2021 · 85 citations · Cited by this paper
  33. Cell cycle dysregulation in cancer · Antonino Glaviano · 2024 · 77 citations · Cited by this paper
  34. Histamine H3 receptors aggravate cerebral ischaemic injury by histamine-independent mechanisms · Haijing Yan · 2014 · 76 citations · Cited by this paper
  35. In Vitro Glioblastoma Models: A Journey into the Third Dimension · Mayra Paolillo · 2021 · 75 citations · Cited by this paper
  36. Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance · Tongxuan Shang · 2025 · 71 citations · Cited by this paper
  37. A Phase II study of a histamine H3 receptor antagonist GSK239512 for cognitive impairment in stable schizophrenia subjects on antipsychotic therapy · L. Fredrik Jarskog · 2015 · 67 citations · Cited by this paper
  38. Identification of novel β-lactams and pyrrolidinone derivatives as selective Histamine-3 receptor (H3R) modulators as possible anti-obesity agents · Anirban Ghoshal · 2018 · 61 citations · Cited by this paper
  39. Randomized crossover study of the histamine H3 inverse agonist MK-0249 for the treatment of cognitive impairment in patients with schizophrenia · Michael F. Egan · 2013 · 54 citations · Cited by this paper

Source: OpenAlex (CC0)